These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 2410522)

  • 1. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.
    Charhon SA; Chavassieux PM; Chapuy MC; Boivin GY; Meunier PJ
    J Lab Clin Med; 1985 Aug; 106(2):123-31. PubMed ID: 2410522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.
    Parisien M; Charhon SA; Arlot M; Mainetti E; Chavassieux P; Chapuy MC; Meunier PJ
    J Bone Miner Res; 1988 Jun; 3(3):259-67. PubMed ID: 3213621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig.
    Sedman AB; Alfrey AC; Miller NL; Goodman WG
    J Clin Invest; 1987 Jan; 79(1):86-92. PubMed ID: 3793934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of osteomalacia in the rat with acute aluminum toxicity.
    Rodriguez M; Felsenfeld AJ; Llach F
    J Bone Miner Res; 1989 Oct; 4(5):687-96. PubMed ID: 2816514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia.
    Goodman WG
    J Lab Clin Med; 1984 May; 103(5):749-57. PubMed ID: 6715954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental aluminum intoxication and parathormone: effects on the mineralization process.
    Ballanti P; Mocetti P; Della Rocca C; Bonucci E; Costantini S; Giordano R; Ioppolo A; Mantovani A
    Miner Electrolyte Metab; 1989; 15(4):233-40. PubMed ID: 2761490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteomalacia and aplastic bone disease in aluminum-related osteodystrophy.
    Andress DL; Maloney NA; Coburn JW; Endres DB; Sherrard DJ
    J Clin Endocrinol Metab; 1987 Jul; 65(1):11-6. PubMed ID: 3584392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of parathyroidectomy on bone formation and mineralization in hemodialyzed patients.
    Charhon SA; Berland YF; Olmer MJ; Delawari E; Traeger J; Meunier PJ
    Kidney Int; 1985 Feb; 27(2):426-35. PubMed ID: 2581010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone histology in adults with aseptic necrosis. Histomorphometric evaluation of iliac biopsies in seventy-seven patients.
    Arlot ME; Bonjean M; Chavassieux PM; Meunier PJ
    J Bone Joint Surg Am; 1983 Dec; 65(9):1319-27. PubMed ID: 6361038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of systemic aluminum on the resolution of a uremic and dietary phosphorus-dependent model of uremic osteomalacia in rats.
    Lieuallen WG; Weisbrode SE
    J Bone Miner Res; 1991 Jul; 6(7):751-7. PubMed ID: 1950679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histomorphometric evidence of deleterious effect of aluminum on osteoblasts.
    de Vernejoul MC; Belenguer R; Halkidou H; Buisine A; Bielakoff J; Miravet L
    Bone; 1985; 6(1):15-20. PubMed ID: 2581595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine-induced bone changes in haemodialysis patients: a histomorphometric study.
    Charhon SA; Chavassieux P; Boivin G; Parisien M; Chapuy MC; Traeger J; Meunier PJ
    Clin Sci (Lond); 1987 Aug; 73(2):227-34. PubMed ID: 3652627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminium-induced osteomalacia in severe chronic renal failure (SCRF).
    Visser WJ; Van de Vyver FL
    Clin Nephrol; 1985; 24 Suppl 1():S30-6. PubMed ID: 3915958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH; Goldstein DA; Massry SG
    J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB; Hood SA; Brown P; Cordy PE
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological quantitation of aluminum in iliac bone from patients with renal failure.
    Maloney NA; Ott SM; Alfrey AC; Miller NL; Coburn JW; Sherrard DJ
    J Lab Clin Med; 1982 Feb; 99(2):206-16. PubMed ID: 6174656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.